Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy (ZLd_Ld)
This study is not yet open for participant recruitment.
Verified December 2011 by University of Turin, Italy
Sponsor:
University of Turin, Italy
Information provided by (Responsible Party):
Antonio Palumbo, University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT01501370
First received: December 16, 2011
Last updated: December 28, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | February 2017 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |